R-Pharm
Manufacturing · Russia · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Leninsky Prospekt K 111 1, Moscow, Mosco...Phone Number
+7 4959567937Website
www.r-pharm.comRevenue
$1.7 BillionIndustry
About R-Pharm
R-Pharm Org Chart
Is R-Pharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
R-Pharm, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if R-Pharm has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when R-Pharm launches new products
Earning: See what the market has to say on R-Pharm recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if R-Pharm is spiking on competitors!
Click to see if R-Pharm had a recent Job posting/layoffs
Funding: Get notified immidiatlly once R-Pharm has new funding data
Congratulate Masked Content for being promoted to Masked Content at R-Pharm
Recommended Actions
Find VP level buyers at R-Pharm
Find more new buyers
Company Profile Activity
Activity Insights
R-Pharm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
R-Pharm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about R-Pharm.
R-Pharm Tech Stack
A closer look at the technologies used by R-Pharm
Most Recent Scoops
R-Pharm News & Media
R-Pharm’s Bloom Beauty Essence® Debuted at ECRM’s Annual Vitamin, Weight Management, Beverage & Sports Nutrition Program
Skincare Supplements and Collagen Drinks Coming Soon to American Consumers Skincare Supplements and Collagen Drinks Coming Soon to American ConsumersCromos Pharma Supports R-Pharm in Initiation of a Global Program to Test Two of its Leading Candidates in Patients with Severe COVID-19 Infection. First Patients Have Been Recruited
MOSCOW and PORTLAND, Ore., April 28, 2020 (GLOBE NEWSWIRE) -- R-Pharm JSC and Cromos Pharma today announced that it has randomized the first patients into a clinical trial evaluating Olokizumab and RPH-104 in patients with severe COVID-19 infection. Olokizumab (OKZ) is a humanized monoclonal antibody with high affinity for interleukin-6 (IL-6), and RPH-104 is a fusion protein that selectively binds and inactivates interleukin-1ß (IL-1ß). The overactive inflammatory response also called the “cyto
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding R-Pharm
Founded in 2001 and headquartered in Moscow, Russia, R-Pharm is a pharmaceutical company. The company is involved in R&D, manufacturing (finished dosage forms, biotech and chemical APIs), marketing, sales and distribution of innovative pharmaceutical products in hospital/specialty care therapeutic areas.... Read More